Literature DB >> 6626840

Hypertension, multi-infarct dementia and Alzheimer's disease.

D St Clair, L J Whalley.   

Abstract

Retrospective review of 89 patients with pre-senile dementia followed by necropsy indicated significant differences between sub types of dementia. Patients with multi-infarct dementia (MID, 27 subjects) more often had cardiovascular abnormalities than patients with Alzheimer's disease (46 subjects). No patients with MID alone had a systolic blood pressure below 140 mm Hg, whereas 23 of 46 Alzheimer subjects and three of 16 patients with mixed features had such a systolic pressure.

Entities:  

Mesh:

Year:  1983        PMID: 6626840     DOI: 10.1192/bjp.143.3.274

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

1.  High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey.

Authors:  Thomas Olabode Obisesan; Odunayo Abiodun Obisesan; Sayyida Martins; Laila Alamgir; Vernon Bond; Celia Maxwell; Richard Frank Gillum
Journal:  J Am Geriatr Soc       Date:  2008-01-04       Impact factor: 5.562

2.  Cerebrovascular disease in dementia: the importance of atrial fibrillation.

Authors:  P J Ratcliffe; G K Wilcock
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

3.  Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study.

Authors:  T Erkinjuntti; M Haltia; J Palo; R Sulkava; A Paetau
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

Review 4.  Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias.

Authors:  A F Jorm
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 5.  Hypertension and cognitive function.

Authors:  Thomas Olabode Obisesan
Journal:  Clin Geriatr Med       Date:  2009-05       Impact factor: 3.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.